{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:11Z","timestamp":1759336571280,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.annpat.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T01:38:41Z","timestamp":1480469921000},"page":"369-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Les tumeurs uroth\u00e9liales en 2016\u00a0: sommes-nous aujourd\u2019hui \u00e0 l\u2019aube d\u2019une nouvelle \u00e8re diagnostique et th\u00e9rapeutique\u00a0?"],"prefix":"10.1016","volume":"36","author":[{"given":"Christian","family":"Pfister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. II","key":"10.1016\/j.annpat.2016.11.001_bib0005","first-page":"103","article-title":"Recommandations en onco-urologie 2013\u00a0: tumeurs de la vessie","volume":"24","author":"Pfister","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organisation\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage ta t1\u00a0bladder cancer using eortc risk tables: a combined analysis of 2596\u00a0patients from seven eortc trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1\u00a0urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexamino levulinate cystoscopy: meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0030","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Randomized study of maintenance bacillus Calmette-Guerin in intermediate and high risk Ta, T1\u00a0papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1\u00a0year versus 3\u00a0years of maintenance. Final results of an EORTC-GU Cancers Group","volume":"63","author":"Oddens","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/iju.12609","article-title":"Efficacy and tolerance of third dose BCG maintenance therapy every 3\u00a0or 6\u00a0months: two years results of URO-BCG 4\u00a0phase III multicenter study (CCAFU)","volume":"22","author":"Pfister","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0045","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.juro.2006.07.132","article-title":"Molecular profiling of bladder tumors based on the detection of FGFR3\u00a0and TP53\u00a0mutations","volume":"176","author":"Lamy","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0050","first-page":"1737","article-title":"Predictive value of genes NRAMP1\u00a0and hGPX1\u00a0polymorphism for maintenance BCG response in non muscle invasive bladder cancer","volume":"36","author":"Lenormand","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annpat.2016.11.001_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"The cancer genome atlas research network comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.annpat.2016.11.001_bib0060","first-page":"202","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Advanced bladder cancer (abc) meta-analysis collaboration","volume":"4","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.annpat.2016.11.001_bib0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.celrep.2014.10.035","article-title":"Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes","volume":"9","author":"Biton","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.annpat.2016.11.001_bib0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649816301614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649816301614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:32:50Z","timestamp":1759332770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649816301614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0242649816301614"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2016.11.001","relation":{},"ISSN":["0242-6498"],"issn-type":[{"type":"print","value":"0242-6498"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les tumeurs uroth\u00e9liales en 2016\u00a0: sommes-nous aujourd\u2019hui \u00e0 l\u2019aube d\u2019une nouvelle \u00e8re diagnostique et th\u00e9rapeutique\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}